Recombinant Anti-EGFR (Clone Matuzumab)
Applications | Bl, ELISA, FC, IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone Matuzumab)
Applications | Bl, ELISA, FC, IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
Applications | Bl, ELISA, FC, IHC |
Reactivities | Human, Chimpanzee |
Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone C225 (Cetuximab))
Applications | Bl, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
Applications | Bl, FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
Applications | ELISA, FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |